Multiple myeloma in a resource constrained setting

Vitamin D in patients with low tumour-burden indolent non-Hodgkin lymphoma treated with rituximab therapy

Synthetic biology and precision medicine in blood and gynaecological cancers

Relapsed refractory multiple myeloma

Hope vs Hype of evidence interpretation

Real world evidence research – asking the right question

Improving design of clinical trials

Steps in clinical research- From an idea to a study

Doable clinical research in LMICs

Cabozantinib shows clinically meaningful improvement in advanced neuroendocrine tumours

Tisotumab vedotin shows clinically meaningful OS improvement versus chemo for metastatic cervical cancer

Pembrolizumab plus chemoradiotherapy shows clinically meaningful improvement in PFS for locally advanced cervical cancer